The Clinical Efficacy of Midline Catheters

University of Aarhus

Status: Completed

Conditions: Intravenous Catheters

Treatments: Device: Midline; Device: PVC and/or PICCline

Study type: Interventional

Funder types: Other

Identifiers

NCT03457259

midlineivauh18

Details and patient eligibility

About

The study will evaluate the clinical efficacy of midline catheters compared to conventional treatment in patients with an expected intravenous therapy duration of more than 5 days. Patients will be randomized in a 1:1 ratio. The study will include 120 patient. Endpoints include insertion of CVSs, peripheral venous catheters, catheter patency and a number of possible complications.

Enrollment: 120 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Admission to the Department of Infectious Disease or Department of Heart Disease.
• ≥18 years of age
• Expected requirement for iv. therapy >5 days from the day of enrolment as evaluated by a specialist in infectious diseases.
• Mentally competency

Exclusion criteria

• Lack of patient consent
• Requirement for a CVC before study eligibility screening or anticipation of an absolute indication for CVC inserted within 24 hours of screening
• Personnel for insertion of midline catheter not available

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

120 participants in 2 patient groups

Midline

Active Comparator group

Description:

Pt. will receive midline catheters. The outcomes will be registered and some patients will be examined once weekly for thrombosis with ultrasound.

Treatment:

Device: Midline

Conventional

Active Comparator group

Description:

Pt. will receive the conventional treatment (PVC and/or PICCline/CVC). The outcomes will be registered.

Treatment:

Device: PVC and/or PICCline